Drug Database
Back to search

United States· US:23731-7000_f07bc3c3-29f0-4f71-9696-47a1c2ec5bf2

Rejuvesol

A medicinal product containing sodium pyruvate; inosine; adenine; sodium phosphate, dibasic; sodium phosphate, monobasic, monohydrate, registered in United States by Citra Labs, LLC.

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedRejuvesolATC—REGISTER NO.US:23731-7000_f07bc3c…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about sodium pyruvate; inosine; adenine; sodium phosphate, dibasic; sodium phosphate, monobasic, monohydrateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
SODIUM PYRUVATE; INOSINE; ADENINE; SODIUM PHOSPHATE, DIBASIC; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
Manufacturer
Citra Labs, LLC
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    2373170005
    12 VIAL, SINGLE-USE in 1 CASE (23731-7000-5) / 50 mL in 1 VIAL, SINGLE-USE
  • ndc11
    23731-7000-5

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/aa0a7ed4-e24c-41b1-b5a9-87fda1f51743
GET /v1/drugs/aa0a7ed4-e24c-41b1-b5a9-87fda1f51743?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "EXTRACORPOREAL",
  "source": "ndc",
  "strength": ".55; 1.34; .034; .73; .311",
  "substance": "SODIUM PYRUVATE; INOSINE; ADENINE; SODIUM PHOSPHATE, DIBASIC; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE",
  "productndc": "23731-7000",
  "dosage_form": "SOLUTION",
  "dea_schedule": null,
  "strength_unit": "g/50mL; g/50mL; g/50mL; g/50mL; g/50mL",
  "application_number": "BN950522",
  "marketing_category": "NDA"
}
API referenceMCP serverPlans

See everything about sodium pyruvate; inosine; adenine; sodium phosphate, dibasic; sodium phosphate, monobasic, monohydrate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console